QURE Stock Analysis: Buy, Sell, or Hold?
QURE - uniQure N.V.
$48.85
-0.19 (-0.39%)
▼
5d:
+80.99%
30d:
+101.94%
90d:
+221.81%
WAIT
LOW Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Smart Money Distribution
None View Scanner →
Strength: 6.8/10
Get Alerted When QURE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: QURE is 25.7% above its trading range ($38.86). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: QURE is 25.7% above its trading range ($38.86). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: QURE is currently trading at $48.85, which is considered extended relative to its 30-day fair value range of $22.10 to $38.86.
Technical Outlook: Technically, QURE is in a uptrend. The price is approaching resistance at $50.08. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: QURE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $58.46 (+19.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QURE is in a uptrend. The price is approaching resistance at $50.08. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: QURE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $58.46 (+19.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$22.10 -
$38.86
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
50.0%
Protect Your Profits
QURE is technically overbought (RSI 77). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+25.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($58.46)
- WARNING: Recommendation downgraded due to 25.7% overvaluation
Trading Range Analysis
30-Day Trading Range
$22.10 -
$38.86
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$25.97
Resistance Level
$50.08
Current Trend
Uptrend
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-18.87
Wall Street Target
$58.46
(+19.7%)
Revenue Growth (YoY)
127.3%
Earnings Growth (YoY)
-18.2%
Share & Embed Analysis
Last updated: June 25, 2026 3:11 AM ET
Data refreshes hourly during market hours. Next update: 4:11 AM
Data refreshes hourly during market hours. Next update: 4:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QURE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeannette Potts
SELL
3412 shares
2026-03-04
Matthew C Kapusta
SELL
14581 shares
2026-03-04
Walid Abi-Saab
SELL
808 shares
2026-03-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 60 BUY |
Advanced QURE Option Strategies
Professional options setups generated by AI based on today's QURE price and gamma walls.
